ASTH Stock Summary and Trading Ideas (Astrana Health | NASDAQ:ASTH)

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Astrana Health trades on the NASDAQ stock market under the symbol ASTH.

As of November 12, 2026, ASTH stock price declined to $31.77 with 319,472 million shares trading.

ASTH has a beta of 1.33, meaning it tends to be more sensitive to market movements. ASTH has a correlation of 0.08 to the broad based SPY ETF.

ASTH has a market cap of $1.58 billion. This is considered a Small Cap stock.

Last quarter Astrana Health reported $1 billion in Revenue and $.26 earnings per share. This beat revenue expectation by $3 million and missed earnings estimates by -$.53.

The top ETF exchange traded funds that ASTH belongs to (by Net Assets): IJR, VTI, IWM, VB, VBK.

ASTH has outperformed the market in the last year with a return of +34.8%, while the SPY ETF gained +11.9%. However, in the most recent history, ASTH shares have underperformed the stock market with its stock returning -11.2% in the last 3 month period and -13.2% for the last 2 week period, while SPY has returned -1.7% and -1.6%, respectively.

ASTH support price is $32.03 and resistance is $33.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASTH shares will trade within this expected range on the day.